Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

BSc2118

SKU: orb1740967

Description

BSc2118 is a potent proteasome inhibitor demonstrating significant antimyeloma activity in vitro and in vivo, positioning it as a promising candidate for oncology drug development. Furthermore, its neuroprotective properties show potential for stroke therapy, including mitigation of thrombolytic agent-induced brain toxicity.

Images & Validation

Key Properties

CAS Number863924-64-5
MW533.66
FormulaC28H43N3O7
SMILES[C@@H](NC([C@@H](NC(OCC1=CC=CC=C1)=O)CC(C)C)=O)(C(N[C@@H](CC(C)C)C=O)=O)CC(OC(C)(C)C)=O
TargetOthers

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

25 mg
$ 1,560.00
50 mg
$ 2,020.00
100 mg
$ 2,540.00
DispatchUsually dispatched within 6-8 weeks
Bulk Enquiry